#Marijuana/ #Hemp #Stocks $ACOL, $ACAN, $CANL, $CRTL, $ETST, $EMC.V, $CHV.CA, $CRZ.CA Just added
Investorideas Also Adds #Technology, #Mining, #Energy & #Biotech Stocks
Point Roberts, WA, Delta BC – December 16, 2016 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its membership global stock directories in marijuana/hemp, technology, mining, energy and biotech.
Marijuana/hemp additions include Canadian and US listed companies involved in Cannabidiol Oil, hemp-based clothing, medical and recreational marijuana, medical storage containers (for medical marijuana) and a business services company that is cannabis industry specific.
The latest tech company to be added is Ericsson (Nasdaq:ERIC) a company that enjoys relationships with every major telecom operator in the world. Look for our exciting new sector “Artificial Intelligence (AI) & Robotics” in next week’s update.
Canadian oil and natural gas company Petrolympic (TSX: PCQ.V; OTCQB: PCQRF), based out of Quebec has been added to both the natural gas stock directory and the oil and gas stock list.
In the mining sector, three new Canadian companies have been added – two involved in exploration and one in the acquisition and management of royalties.
The latest biotech additions focus on women’s health, cardiovascular disease, Wilson Disease, (a genetic disorder that causes copper to build up in the body), respiratory disease and a company dedicated to therapeutic antibody discovery and commercialization.
Read this release in full at http://www.investorideas.com/news/2016/marijuana/12161Update.asp
New Marijuana Companies Added:
Acology Inc (OTC:ACOL), Americann Inc (OTC:ACAN), Canada House Wellness Group Inc.(CSE:CHV), CannaRoyalty Corp. (CSE:CRZ), CannLabs Inc (OTC:CANL), Cartel Blue (OTC:CRTL), Earth Science Tech Inc (OTC:ETST) and Emblem Corp. (TSX:EMC.V)
New Technology Companies Added:
Ericsson (Nasdaq:ERIC) is the driving force behind the Networked Society - a world leader in communications technology and services. Our long-term relationships with every major telecom operator in the world allow people, business and society to fulfill their potential and create a more sustainable future. Our services, software and infrastructure - especially in mobility, broadband and the cloud - are enabling the telecom industry and other sectors to do better business, increase efficiency, improve the user experience and capture new opportunities. With approximately 115,000 professionals and customers in 180 countries, we combine global scale with technology and services leadership. We support networks that connect more than 2.5 billion subscribers. Forty percent of the world's mobile traffic is carried over Ericsson networks. And our investments in research and development ensure that our solutions - and our customers - stay in front. Founded in 1876, Ericsson has its headquarters in Stockholm, Sweden.
New Mining Companies Added:
Goldbelt Empires Limited (TSX: GBE.V) is a gold explorer focused on the West African Goldbelt, and listed its shares on the TSX Venture Exchange in October 2015. Its flagship property is the South Morila gold concession in the Republic of Mali. The South Morila concession covers an area approximately 150 km2 in size, and is located in the southern part of Mali approximately 250 km southeast of the capital of Bamako
Jaxon Minerals (TSX:JAX.V) is a base and precious metals exploration company with a regional focus on Western Canada. The company is currently advancing its optioned Price Creek property in north-central British Columbia. The property has seen considerable historic exploration work and presents a volcanogenic massive sulphide-style target with reported potential Eskay Creek/Equity silver- style mineralization.
Metalla Royalty and Streaming Ltd. (formerly Excaliber Resources) (CSE:MTA) is a precious metals royalty and streaming company engaged in the acquisition and management of precious metal royalties, streams and similar production based interests.
New Energy Companies Added:
Petrolympic Ltd. (TSX: PCQ.V; OTCQB: PCQRF) is a Canadian junior oil and gas company actively exploring for premium light crude oil and natural gas in North America. The Company is presently focused on its near-term conventional oil and natural gas production assets in the Gaspe Peninsula, Province of Quebec, Canada. The Company also holds natural gas assets in the Utica Fairway of Quebec and an 8,000+ acre asset in the oil-prolific Maverick Basin of Texas, USA. The land position in Quebec consists of 100% interest in 5 exploration permits over 239,296 acres (96,840 hectares), 30% interest in 36 exploration permits totaling 1,601,466 acres (648,093 hectares) and 12% interest in 19,768 acres (8,000 hectares). Petrolympic is targeting hydrothermal dolomite and naturally fractured hosted conventional light oil and natural gas in areas where hydrocarbon shows have been previously documented in geological outcrop sampling and coring programs together with its private joint venture partner Ressources et Energie Squatex Inc. The partnership has recently discovered a conventional gas reservoir, heavy oil and condensates in the Masse structure located in the Gaspe Peninsula.
New Biotech Companies Added:
Juniper Pharmaceuticals, Inc. (NasdaqGS:JNP) is focused on developing therapeutics that address unmet medical needs in women's health. The Company is advancing a pipeline of proprietary product candidates that leverage its differentiated intravaginal ring technology and the 505(b)(2) regulatory pathway. Juniper's core operating business includes the Crinone® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients.
Quantum Genomics (Paris:ALQGC.PA) is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure. Quantum Genomics is developing a new therapeutic approach based on BAPAI (Brain Aminopeptidase A Inhibition). This is the result of more than 20 years of academic research in the laboratories of the Collège de France, INSERM, CNRS and the University of Paris Descartes. The Company has offices in Paris, France and New York, NY, USA.
uniQure N.V. (NasdaqGS:QURE) is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with liver/metabolic, central nervous system and cardiovascular diseases.
Wilson Therapeutics AB (Stockholm: WTX.ST) is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases. Wilson Therapeutics’ lead product, WTX101, is initially being developed as a novel treatment for Wilson Disease and has been evaluated in a Phase 2 clinical study. Wilson Therapeutics is listed in the Mid Cap segment on Nasdaq Stockholm with the stock ticker WTX.
Windtree Therapeutics, Inc. (NasdaqCM:WINT) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree's proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.
XBiotech USA, Inc. (NasdaqGS:XBIT) is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human(TM) proprietary technology. XBiotech currently is advancing a robust pipeline of antibody therapies to redefine the standards of care in oncology, inflammatory conditions and infectious diseases. Headquartered in Austin, Texas, XBiotech also is leading the development of innovative biotech manufacturing technologies designed to more rapidly, cost-effectively and flexibly produce new therapies urgently needed by patients worldwide.
Investorideas.com global stock directories are part of its membership program, accessed either by login and password or available in PDF format. The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!
Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.